Simplex Trading
FLGT icon

Simplex Trading’s Fulgent Genetics FLGT Stock Holding History

Simplex Trading’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.18K Sell
200
-11,300
-98% -$245K ﹤0.01% 8153
2025
Q4 		$302K Buy
11,500
+11,300
+5,650% +$293K ﹤0.01% 3808
2025
Q3 		$4K Sell
200
-300
-60% -$6.18K ﹤0.01% 8406
2025
Q2 		$9K Buy
500
+200
+67% +$3.9K ﹤0.01% 7377
2025
Q1 		$5K Buy
+300
New +$5.11K ﹤0.01% 7541
2024
Q4 		– Sell
-400
Closed -$8K – 8856
2024
Q3 		$8K Sell
400
-5,800
-94% -$130K ﹤0.01% 7317
2024
Q2 		$121K Buy
6,200
+1,900
+44% +$39.7K ﹤0.01% 5174
2024
Q1 		$93K Sell
4,300
-100
-2% -$2.48K ﹤0.01% 5661
2023
Q4 		$127K Buy
4,400
+1,700
+63% +$45.5K ﹤0.01% 5131
2023
Q3 		$72K Sell
2,700
-3,100
-53% -$106K ﹤0.01% 5438
2023
Q2 		$214K Sell
5,800
-4,700
-45% -$164K ﹤0.01% 4227
2023
Q1 		$327K Buy
10,500
+700
+7% +$22.5K ﹤0.01% 3734
2022
Q4 		$291K Sell
9,800
-10,900
-53% -$390K ﹤0.01% 3777
2022
Q3 		$789K Sell
20,700
-300
-1% -$15K ﹤0.01% 2930
2022
Q2 		$1.15M Buy
21,000
+7,600
+57% +$418K ﹤0.01% 2468
2022
Q1 		$836K Buy
13,400
+2,400
+22% +$158K ﹤0.01% 3128
2021
Q4 		$1.11M Sell
11,000
-26,100
-70% -$2.29M ﹤0.01% 2729
2021
Q3 		$3.24M Buy
37,100
+300
+0.8% +$27.3K ﹤0.01% 1593
2021
Q2 		$3.39M Buy
36,800
+36,352
+8,114% +$2.9M ﹤0.01% 1551
2021
Q1 		$4.33M Buy
448
+127
+40% +$13.1K 0.01% 937
2020
Q4 		$1.67M Buy
321
+308
+2,369% +$12.9K ﹤0.01% 1959
2020
Q3 		$52K Buy
+13
New +$407 ﹤0.01% 5565

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Simplex Trading's FLGT Position: Q3 2025 in Review

Simplex Trading sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 10,821 shares — an estimated $223K sold.

Simplex Trading first reported a position in FLGT in Q3 2020 and held it in 13 quarters. The position peaked at $1.09M in Q4 2020. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Simplex Trading reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 10,821 Fulgent Genetics shares in Q3 2025, an estimated $223K.
  • Simplex Trading first reported a position in Fulgent Genetics in Q3 2020 and held it in 13 quarters.
  • Simplex Trading's Fulgent Genetics position peaked at $1.09M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.